SkyWest Inc. (SKYW) reported a strong third quarter for 2025, with earnings per share (EPS) of $2.81, surpassing the forecast of $2.50. Despite this positive earnings surprise of 12.4%, the company’s ...
Oct. 31, 2025: National Advocacy Update FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy Update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback